Endocrine Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
JAMA Surg. 2019 Jan 1;154(1):40-45. doi: 10.1001/jamasurg.2018.3475.
Neuroendocrine tumors (NETs) express somatostatin receptors, which can be targeted with radiolabeled peptides. In a variety of solid tumors, radioguided surgery (RGS) has been used to guide surgical resection. Gallium 68 (68Ga) dota peptides have been shown to be more accurate than other radioisotopes for detecting NETs. A pilot study previously demonstrated the feasibility and safety of 68Ga-dotatate RGS for patients with NETs.
To evaluate what intraoperative techniques and thresholds define positive lesions that warrant resection during 68Ga-dotatate RGS.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study, conducted between October 23, 2013, and February 14, 2018, included 44 patients with NETs who underwent 68Ga-dotatate RGS.
Gallium 68-dotatate RGS.
The in vivo and ex vivo tumor to background ratio (TBR) was assessed for resected lesions and correlated with the histopathologic findings.
Forty-four patients (22 women and 22 men; mean [SD] age, 51.0 [13.7] years) had 133 lesions detected on preoperative imaging scans, with a diagnosis of a pancreatic NET (19 of 44 [43%]), gastrointestinal NET (22 of 44 [50%]), and pheochromocytoma or paraganglioma (3 of 44 [7%]). The TBR was obtained by normalizing to the omentum (106 of 133 [79.7%]) or other solid organs (27 of 133 [20.3%]). The omentum had a significantly lower mean (SD) count than other solid organs for background count activity 3 hours after injection (22.1 [17.0] vs 34.5 [39.0]; P < .001). The lesions containing NETs had a higher TBR than those that did not contain NETs (18.9 vs 4.4; P < .001). On a receiver operating characteristic curve analysis, a TBR of 2.5 had a sensitivity of 90% and a specificity of 25%, and a TBR of 16 had a sensitivity of 54% and a specificity of 81%.
A TBR of 2.5 or greater is a highly sensitive threshold for indicating a lesion to be consistent with a NET on histologic findings and thus warranting surgical resection. The omentum should be used as the background count activity for 68Ga-dotatate RGS for patients with abdominal NETs.
神经内分泌肿瘤 (NET) 表达生长抑素受体,可用放射性标记肽靶向。在各种实体肿瘤中,放射性导向手术 (RGS) 已用于指导手术切除。镓 68(68Ga)dota 肽已被证明比其他放射性同位素更能准确地检测 NET。一项初步研究先前证明了 68Ga-dotatate RGS 用于 NET 患者的可行性和安全性。
评估 68Ga-dotatate RGS 中定义需要切除的阳性病变的术中技术和阈值。
设计、地点和参与者:这项前瞻性队列研究于 2013 年 10 月 23 日至 2018 年 2 月 14 日进行,包括 44 名接受 68Ga-dotatate RGS 的 NET 患者。
镓 68-dotatate RGS。
对切除的病变进行体内和体外肿瘤与背景比(TBR)评估,并与组织病理学发现相关联。
44 名患者(22 名女性和 22 名男性;平均[标准差]年龄 51.0[13.7]岁)在术前影像学扫描中发现 133 个病变,诊断为胰腺 NET(19/44 [43%])、胃肠道 NET(22/44 [50%])和嗜铬细胞瘤或副神经节瘤(3/44 [7%])。通过将腹膜(133 个中的 106 个[79.7%])或其他实体器官(133 个中的 27 个[20.3%])标准化来获得 TBR。与其他实体器官相比,注射后 3 小时腹膜的背景计数活性具有明显更低的平均值(标准差)计数(22.1[17.0]与 34.5[39.0];P < .001)。包含 NET 的病变的 TBR 高于不包含 NET 的病变(18.9 与 4.4;P < .001)。在受试者工作特征曲线分析中,TBR 为 2.5 时的灵敏度为 90%,特异性为 25%,TBR 为 16 时的灵敏度为 54%,特异性为 81%。
TBR 为 2.5 或更高是指示病变与组织学发现一致的 NET 的高度敏感阈值,因此需要手术切除。对于腹部 NET 患者,应使用腹膜作为 68Ga-dotatate RGS 的背景计数活性。